Alisun Pharma Private Limited
About Alisun Pharma Private Limited
Data last updated:
Alisun Pharma Private Limited is a private limited company based in Delhi, India. It operates in the management consultancy segment of the business services sector. It was incorporated on 05 March 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24233DL2014PTC265850. Its GSTIN is 09AAMCA4838R1ZR (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors Devesh Gupta and Anil Kumar Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H.No.544B 3rd Floor Office No.77 Shiv Arcade A/2 Acharya Niketan Mayur Vihar, Delhi, India – 110091.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.88 Cr, a growth of 22% compared to the previous year. For the same year it recorded a net loss of ₹4.33 Lakh (net margin -1.5%) and EBITDA of -₹4.33 Lakh (EBITDA margin -1.5%). Revenue has declined at a compounded annual rate (CAGR) of 1% over three years and 10% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Alisun Pharma Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressH.No.544B 3rd Floor Office No.77 Shiv Arcade A/2 Acharya Niketan Mayur Vihar, Delhi, India – 110091
- IndustryBusiness Services, Management Consultancy
To see the full contact details of Alisun Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Alisun Pharma is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Alisun Pharma Private Limited, buy the company report.
Financials of Alisun Pharma Private Limited
FY 2025 filings availableAlisun Pharma Private Limited reported revenue of ₹2.88 Cr (up 22% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 22% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 10%. EBITDA fell 280% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹4.33 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹4.33 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -1.5% | ||||
| Net Profit Margin | -1.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Alisun Pharma Private Limited, buy the company report.
Board of directors of Alisun Pharma Private Limited
Alisun Pharma has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Devesh Gupta Also directs: Avancer Labs Private Limited, Ridhi Hospital LLP | Director | 05 Mar 2014 | 12 Years 7 Months | Current |
| Anil Kumar Gupta Also directs: Ablin Pharma Private Limited, Avancer Labs Private Limited | Director | 05 Mar 2014 | 12 Years 7 Months | Current |
Peer comparison
Alisun Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Medisurya Medicals Private Limited | ₹2.88 Cr (FY 2025) | 2.0% | Kowdiar P O, Kerala, India | |||
| Rhino Engineers Private Limited | ₹2.88 Cr (FY 2025) | 51.0% | Ahmedabad, Gujarat, India | |||
| Shreesadguru Fashion Private Limited | ₹2.88 Cr (FY 2025) | -10.0% | Pune, Maharashtra, India | |||
| Indsafe Marketing Private Limited | ₹2.88 Cr (FY 2025) | -16.0% | Panaji, Goa, India | |||
| Cresent Commodeal Pvt.Ltd. | ₹2.88 Cr (FY 2024) | 1172.0% | Kolkata, West Bengal, India | |||
| Alisun Pharma Private Limitedthis company | ₹2.88 Cr (FY 2025) | -₹4.33 Lakh | -1.5% | 22.0% | Delhi, India | |
| Hera Impex Private Limited | ₹2.87 Cr (FY 2025) | -34.0% | Chennai, Tamil Nadu, India | |||
| Shriunimax Corporation Limited | ₹2.87 Cr (FY 2016) | -10.0% | Kanpur, Uttar Pradesh, India | |||
| Shankesh Foods and Exports Private Limited | ₹2.87 Cr (FY 2020) | -22.0% | Indore, Madhya Pradesh, India | |||
| Puls Multi Specialty Medical Research Centre (I) Private Limited | ₹2.87 Cr (FY 2025) | 75.0% | Deoria, Uttar Pradesh, India | |||
| Sandeep Home Emporium Private Limited | ₹2.87 Cr (FY 2022) | 72.0% | Bangalore, Karnataka, India |
To see the full peer comparison of Alisun Pharma Private Limited, buy the company report.
Auditor
Alisun Pharma Private Limited is audited by SUNIL KOTHARI & CO for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SUNIL KOTHARI & CO | FY 2017 | 025944N |
Shareholding
The shareholding of Alisun Pharma Private Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Alisun Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Alisun Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Alisun Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Alisun Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAMCA4838R1ZR | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Alisun Pharma Private Limited, buy the company report.
Recent activity
Alisun Pharma Private Limited has 7 board changes on record since 2014: 2 appointments and 5 cessations. The latest: Girjesh Kumar ceased to be Additional Director on 09 Aug 2023.
Frequently asked questions
Alisun Pharma is an active private limited company based in Delhi, India. The company works in management consultancy, within the business services industry. It was incorporated on 05 March 2014 (12+ years old) and is registered under CIN U24233DL2014PTC265850.
Alisun Pharma has 2 current directors:
- Devesh Gupta - Director
- Anil Kumar Gupta - Director
The latest financial statements of Alisun Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Alisun Pharma is 09AAMCA4838R1ZR, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Alisun Pharma is U24233DL2014PTC265850. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Alisun Pharma was incorporated on 05 March 2014, making it 12+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Alisun Pharma by revenue are Medisurya Medicals Private Limited, Rhino Engineers Private Limited, Shreesadguru Fashion Private Limited, Indsafe Marketing Private Limited, Cresent Commodeal Pvt.Ltd. and 5 more, all in the same principal business activity (retail trading).
Girjesh Kumar ceased to be Additional Director on 09 Aug 2023. Rajani Chaudhary ceased to be Additional Director on 31 Jul 2016. Vijay Pratap Singh ceased to be Additional Director on 31 Jul 2016. Alisun Pharma has 7 board changes on record in total.
The registered office of Alisun Pharma is at H.No.544B 3rd Floor Office No.77 Shiv Arcade A2 Acharya Niketan Mayur Vihar, Delhi, India – 110091.
Alisun Pharma operates in the business services industry, in the management consultancy segment.
The compliance status of Alisun Pharma is compliant as of 01 August 2026. The company is actively filing with the Registrar of Companies.